Business Description
Sonoscape Medical Corp
ISIN : CNE100002P91
Share Class Description:
SZSE:300633: Class ACompare
Compare
Traded in other countries / regions
300633.China IPO Date
2017-04-06Description
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.57 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 1.64 | |||||
| Interest Coverage | 47.11 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 9.72 | |||||
| Beneish M-Score | -2.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.5 | |||||
| 3-Year EBITDA Growth Rate | 531.5 | |||||
| 3-Year FCF Growth Rate | 34 | |||||
| 3-Year Book Growth Rate | 29.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 20.72 | |||||
| Future 3-5Y Total Revenue Growth Rate | 17.18 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.03 | |||||
| 9-Day RSI | 30.88 | |||||
| 14-Day RSI | 37.06 | |||||
| 6-1 Month Momentum % | -17.75 | |||||
| 12-1 Month Momentum % | -26.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.09 | |||||
| Quick Ratio | 2.26 | |||||
| Cash Ratio | 1.98 | |||||
| Days Inventory | 354.57 | |||||
| Days Sales Outstanding | 32.29 | |||||
| Days Payable | 128.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.01 | |||||
| Dividend Payout Ratio | 0.51 | |||||
| 3-Year Dividend Growth Rate | 90.6 | |||||
| Forward Dividend Yield % | 1.01 | |||||
| 5-Year Yield-on-Cost % | 0.98 | |||||
| 3-Year Average Share Buyback Ratio | -2.2 | |||||
| Shareholder Yield % | 0.36 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.98 | |||||
| Operating Margin % | 12.19 | |||||
| Net Margin % | 11.84 | |||||
| FCF Margin % | 2.73 | |||||
| ROE % | 7.69 | |||||
| ROA % | 6.11 | |||||
| ROIC % | 15.41 | |||||
| ROC (Joel Greenblatt) % | 22.09 | |||||
| ROCE % | 7.61 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 55.31 | |||||
| Forward PE Ratio | 27.24 | |||||
| PE Ratio without NRI | 49.46 | |||||
| Price-to-Owner-Earnings | 144.43 | |||||
| PEG Ratio | 1.36 | |||||
| PS Ratio | 6.56 | |||||
| PB Ratio | 4.27 | |||||
| Price-to-Tangible-Book | 4.84 | |||||
| Price-to-Free-Cash-Flow | 244.54 | |||||
| Price-to-Operating-Cash-Flow | 47.99 | |||||
| EV-to-EBIT | 50.32 | |||||
| EV-to-EBITDA | 50.32 | |||||
| EV-to-Revenue | 6.03 | |||||
| EV-to-FCF | 220.9 | |||||
| Price-to-Projected-FCF | 3.28 | |||||
| Price-to-Graham-Number | 3.27 | |||||
| Price-to-Net-Current-Asset-Value | 7.27 | |||||
| Price-to-Net-Cash | 16.55 | |||||
| Earnings Yield (Greenblatt) % | 1.99 | |||||
| FCF Yield % | 0.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sonoscape Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,050.615 | ||
| EPS (TTM) (Â¥) | 0.557 | ||
| Beta | 0.43 | ||
| Volatility % | 39.51 | ||
| 14-Day RSI | 37.06 | ||
| 14-Day ATR (Â¥) | 1.357734 | ||
| 20-Day SMA (Â¥) | 33.6205 | ||
| 12-1 Month Momentum % | -26.54 | ||
| 52-Week Range (Â¥) | 25.04 - 48.63 | ||
| Shares Outstanding (Mil) | 432.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sonoscape Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sonoscape Medical Corp Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sonoscape Medical Corp Frequently Asked Questions
What is Sonoscape Medical Corp(SZSE:300633)'s stock price today?
The current price of SZSE:300633 is ¥31.11. The 52 week high of SZSE:300633 is ¥48.63 and 52 week low is ¥25.04.
When is next earnings date of Sonoscape Medical Corp(SZSE:300633)?
The next earnings date of Sonoscape Medical Corp(SZSE:300633) is .
Does Sonoscape Medical Corp(SZSE:300633) pay dividends? If so, how much?
The Dividend Yield %  of Sonoscape Medical Corp(SZSE:300633) is 1.01% (As of Today), Highest Dividend Payout Ratio of Sonoscape Medical Corp(SZSE:300633) was 0.51. The lowest was 0.08. And the median was 0.16. The  Forward Dividend Yield % of Sonoscape Medical Corp(SZSE:300633) is 1.01%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers